CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test becomes the only FDA approved companion diagnostic indicated to aid assessment of HER2 low-metastatic breast cancer ...

but this report confirms previous findings on the overexpression of HER2 and blockade of HER2/neu signaling with trastuzumab in these patients.

If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.

O azeite de oliva contém um ácido gordo essencial, o ácido oleico (ómega-9) que diminui os níveis de um dos oncogenes, o HER2/neu. Além disso, aumenta o efeito de outro medicamento utilizado no cancro ...

Purpose: The basic concepts of pharmacogenetics, pharmacogenetic study approaches, factors to consider when applying pharmacogenetic discoveries to patient care, and potential roles for ...